findmyKOL
Clinical trialNCT07232069Not, yet, recruitingPhase 3Interventional

PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

SponsorDuke UniversityEnrollment1,500Coronary Artery Disease ProgressionCoronary Artery Disease Risk Factors MultiplePremature AtherosclerosisPrevention & Control
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama at Birmingham

    Birmingham, Alabama, United States

    Kevin Riggs, MD
  • Cardiology Associates

    Mobile, Alabama, United States

    Jason Cole, MD
  • Lundquist Institute for Biomedical Innovation at Harbor Ucla Medical Center

    Los Angeles, California, United States

    Matthew Budoff, MD
  • University of California, Los Angeles

    Los Angeles, California, United States

    Karol Watson, MD
  • Wellstar Kennestone Hospital

    Hiram, Georgia, United States

    Frank Corrigan, MD
  • University of Chicago

    Chicago, Illinois, United States

    Tamar Polonsky, MD
  • Johns Hopkins University

    Baltimore, Maryland, United States

    Michael Blaha, MD
  • Massachusetts General Hospital Brigham

    Boston, Massachusetts, United States

    Michael Honigberg, MD
  • Essentia Health

    Duluth, Minnesota, United States

    Catherine Benzinger, MD
  • Northern Westchester Hospital

    Mount Kisco, New York, United States

    Dina Katz, MD
  • New York University Langone

    New York, New York, United States

    Harmony Reynolds, MD
  • Weill Cornell Medicine

    New York, New York, United States

    Sam Kim, MD
  • Duke University Hospital

    Durham, North Carolina, United States

    Nishant Shah, MD
  • Wake Forest University, Advocate Health

    Winston-Salem, North Carolina, United States

    Michael Shapiro, MD
  • Oregon Health and Sciences University

    Portland, Oregon, United States

    Maros Ferencik, MD
  • Thomas Jefferson University

    Philadelphia, Pennsylvania, United States

    Chris Chambers, MD
  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, United States

    Anum Saeed, MD
  • Medical University of South Carolina (musc)

    Charleston, South Carolina, United States

    Sheldon Litwin, MD
  • Vanderbilt University

    Nashville, Tennessee, United States

    Deepak Gupta, MD
  • Houston Methodist Hospital

    Houston, Texas, United States

    Khurrrram Nasir, MD
  • University of Virginia (uva)

    Charlottesville, Virginia, United States

    Todd Villines, MD
  • Inova Health System

    Fairfax, Virginia, United States

    Jared Spitz, MD
  • Marshfield Clinical Research Institute

    Marshfield, Wisconsin, United States

    Jeff VanWormer

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jul 2026
Primary completion
31 Jul 2031
Completion
31 Jul 2031
Last update posted
10 Jul 2026
Registered enrollment
1,500
Registry id
NCT07232069

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.